HIGH THROMBOMODULIN PLASMA-LEVELS IN UREMIC PATIENTS ON REGULAR HEMODIALYSIS

被引：0
|
作者：
PAPA, ML
CALDORA, M
CAPASSO, F
SARTI, A
MARINELLI, G
ROCINO, A
BOSSONE, A
DELUCIA, D
DEBIASI, R
机构：
[1] OSPED NUOVO PELLEGRINI,CTR EMOFILIA & TROMBOSI,NAPLES,ITALY
[2] OSPED M SCARLATO,DIV NEFROL & DIALISI,SCAFATI,ITALY
[3] UNIV NAPLES,IST PATOL GEN & ONCOL,I-80138 NAPLES,ITALY
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1431 / 1431
页数：1
相关论文
共 50 条
  • [21] PLASMA-LEVELS OF GASTROINTESTINAL REGULATORY PEPTIDES IN PATIENTS RECEIVING MAINTENANCE HEMODIALYSIS
    HEGBRANT, J
    THYSELL, H
    EKMAN, R
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 (06) : 599 - 604
  • [22] HAIR ZINC COMPARED WITH PLASMA ZINC IN UREMIC PATIENTS BEFORE AND DURING REGULAR HEMODIALYSIS
    MOUNTOKALAKIS, T
    DAKANALIS, D
    BOUKIS, D
    VIRVIDAKIS, K
    VOUDIKLARI, S
    KOUTSELINIS, A
    CLINICAL NEPHROLOGY, 1979, 12 (05) : 206 - 209
  • [23] SCINTIGRAPHIC SKELETAL CHANGES IN UREMIC PATIENTS ON REGULAR HEMODIALYSIS
    OLGAARD, K
    HEERFORDT, J
    MADSEN, S
    NEPHRON, 1976, 17 (05) : 325 - 334
  • [24] METACARPAL CORTICAL THICKNESS IN UREMIC PATIENTS ON REGULAR HEMODIALYSIS
    DELRIO, A
    RICO, H
    CARRERA, F
    TORRENTE, J
    DOCON, MT
    ESPINOS, D
    NEPHRON, 1978, 22 (4-6): : 354 - 360
  • [25] EFFECTS OF ORAL CIMETIDINE ON PARATHYROID-HORMONE AND CALCITONIN PLASMA-LEVELS IN UREMIC PATIENTS
    SEBERT, JL
    DECOURCELLES, PH
    MORINIERE, P
    DEFREMONT, JF
    GUERIS, J
    MAKDASSI, R
    KHASSOUF, J
    ANDREJAK, M
    FOURNIER, A
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1982, 151 : 677 - 684
  • [26] PLASMA VONWILLEBRAND-FACTOR AND THROMBOMODULIN AS MARKERS OF VASCULAR DISORDERS IN PATIENTS UNDERGOING REGULAR HEMODIALYSIS THERAPY
    OHNO, Y
    TOMURA, S
    DEGUCHI, F
    NAKAMURA, Y
    CHIDA, Y
    MARUMO, F
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 946 - 946
  • [27] PLASMA VONWILLEBRAND-FACTOR AND THROMBOMODULIN AS MARKERS OF VASCULAR DISORDERS IN PATIENTS UNDERGOING REGULAR HEMODIALYSIS THERAPY
    TOMURA, S
    NAKAMURA, Y
    DEGUCHI, F
    CHIDA, Y
    OHNO, Y
    KODAMA, S
    HAYASHI, T
    SUZUKI, K
    MARUMO, F
    THROMBOSIS RESEARCH, 1990, 58 (04) : 413 - 419
  • [28] Obstacles to reducing plasma levels of uremic solutes by hemodialysis
    Sirich, Tammy L.
    SEMINARS IN DIALYSIS, 2017, 30 (05) : 403 - 408
  • [29] HEMODIALYSIS - EFFECT ON PLASMA-LEVELS OF VITAMIN-A AND CAROTENOID
    GOTLOIB, L
    SKLAN, D
    MINES, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 239 (08): : 751 - 751
  • [30] SERUM-LIPIDS IN UREMIC PATIENTS RECEIVING REGULAR HEMODIALYSIS
    PIERIDES, AM
    WEIGHTMAN, D
    GOLDFINCH, M
    TSOUKANTAS, T
    KERR, DNS
    KIDNEY INTERNATIONAL, 1975, 8 (02) : 130 - 130
12345